Quality & Compliance
At Vientiane Pharmaceuticals, we work to structure every facility specification, laboratory methodology, and documentation workflow around internationally recognized pharmaceutical quality principles.
Because our facility in Vientiane, Lao PDR is a proposed development, we present our quality architecture transparently as design commitments and operational standards we work toward—not as claims of existing licences, accreditations, or certifications.
Quality Management Architecture
Pharmaceutical quality cannot be achieved through isolated testing of finished units. Instead, we design our Pharmaceutical Quality System to govern the entire lifecycle of materials, utilities, equipment, and documentation—ensuring that every operational decision is traceable, reproducible, and scientifically justified.
Documentation Control
We work to establish a tiered documentation hierarchy comprising a site quality manual, validation master plans, standard operating procedures, master formula records, and batch packaging instructions. Every controlled document is designed to follow strict authoring, independent quality review, version tracking, and archival protocols.
Continuous Oversight
Any proposed modification to a facility utility, equipment component, raw material source, or analytical method is designed to pass through formal change control impact assessment. Unplanned deviations are structured to trigger root-cause investigation and documented Corrective and Preventive Action (CAPA) with effectiveness verification.
Data Integrity
We design both paper-based logbooks and computerized laboratory systems around foundational data integrity principles. Every analytical measurement, balance weighing, and environmental reading is intended to be attributable to the trained operator, recorded contemporaneously, original, accurate, and legible throughout its retention period.
Laboratory Governance
Our planned Quality Control division is structured into specialized physical-chemical, instrumental, and microbiological laboratories that operate independently from manufacturing management. No starting material is intended to enter dispensing, and no finished batch is intended to leave quarantine, without written authorization from designated quality personnel.
Incoming active pharmaceutical ingredients, excipients, and primary packaging materials are planned to undergo quarantine upon arrival, followed by identity confirmation, physical inspection, and pharmacopoeial specification testing prior to release for formulation.
During formulation and packaging, scheduled in-process checks monitor weight uniformity, hardness, friability, disintegration, fill volume, and blister seal integrity. Finished batch testing protocols encompass chemical assay, dissolution profiling, content uniformity, and impurity screening.
Because Vientiane and the wider Mekong region experience high ambient temperatures and elevated monsoon humidity, we work to design stability chambers and real-time retention studies calibrated for hot and humid climatic conditions. These studies guide our choice of moisture-barrier blister films and protective secondary cartons.
Qualification & Regulatory Ethics
Before any pharmaceutical process can be relied upon, the underlying facility utilities, cleanroom envelopes, and analytical instruments must demonstrate consistent performance across their operating ranges.
Verify that architectural layouts, cleanroom air cascades, purified water loops, and equipment specifications align with user requirements and good manufacturing principles.
Document that delivered instruments, HVAC units, and process vessels are installed safely according to engineering drawings, material certificates, and calibration baselines.
Test equipment and environmental controls across upper and lower operating limits—verifying pressure differentials, airflow velocities, and alarm interlocks.
Confirm that integrated systems, cleaning procedures, and analytical methods perform reproducibly under simulated and actual operating conditions.
Transparency & Non-Certification Notice: All quality, laboratory, validation, and compliance descriptions on this page express the technical commitments and intended operational frameworks of Vientiane Pharmaceuticals. We do not claim to hold any current manufacturing authorization, product registration, or third-party quality certification. Review our Project & Medical Disclaimer.
Corporate Correspondence
For quality governance inquiries, technical introductions, or questions regarding our compliance framework, please contact our coordination desk directly by email.
info@
